Sandra Elena Pérez

Sandra Elena Pérez

Auto-generated profile, based on publicly available information

Sandra Elena Pérez

Department of Laboratory Medicine, University Hospital of Salamanca, Salamanca, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
FMFernando Marqués-García
Fernando Marqués-García
David Hansoe Heredero-JungDavid Hansoe Heredero-Jung
David Hansoe Heredero-Jung
SPSandra Elena Pérez
Sandra Elena Pérez
Fernando Marques-Garcia, Ph.D., David Hansoe Heredero Jung, M.D., and Sandra Elena Pérez, B.D.. Ann Lab Med 2022;42:169-77. https://doi.org/10.3343/alm.2022.42.2.169

3 August 2022 in Scandinavian Journal of Clinical and Laboratory Investigation
Verified
Journal Article
Closed access
EMEduardo Martínez-Morillo
Eduardo Martínez-Morillo
SESandra Elena-Pérez
Sandra Elena-Pérez
DCDavid Cembrero-Fuciños
David Cembrero-Fuciños
MGMaría Francisca García-Codesal
María Francisca García-Codesal
TCTeresa Contreras-Sanfeliciano
Teresa Contreras-Sanfeliciano
The verification of examination procedures is a responsibility for clinical laboratories in order to guarantee that their performance characteristics comply with the specifications obtained during the validation process and are congruent with the intended scope of the assay. The aim was to perform an evaluation of precision, bias, linearity, linear drift, sample carry-over, and comparability of 73 assays from Siemens Healthineers, by following the CLSI EP10-A3 guidelines. The verification was performed by measuring 72 biochemical parameters in quality control (QC) materials from Bio-Rad (except for IL6) with 73 assays installed on eight measuring systems (five Atellica® CH 930 and three IM 1600 analyzers from Siemens Healthcare Diagnostics). The following information was collected: validation data from manufacturer, biological variation data from the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) database, and specifications for fβhCG and PAPP-A assays to meet the Fetal Medicine Foundation standards. A total of 17550 results were obtained during EP10 verification process. Out of the 73 methods, only Cl–S, Mg–S, and Na–S failed the criteria for adequate precision, trueness, and comparability. The assays did not show significant loss of linearity, linear drift, or sample carry-over. This study allowed the initial training and familiarization with the instruments and the identification of operational issues. It also represented an opportunity to evaluate the QCs and to obtain analytical performance information for application of sigma six metrics for quality assurance. Professionals are advised to adequately standardize and protocolize their verification processes to ensure laboratory competence and patient safety.